Spermosens Issue Subscribed 121%

Copenhagen, January 25, 2023 Gemstone Capital A/S acted as sole financial advisor to Spermosens AB. What a breeze, that it IS possible to succeed, even in todays tough market. The ingredients: a great little company, attractive terms and a focused campaign. Now, we look forward to the commercialization of Spermosens’ technology that has the potential…

Välkommen att teckna Units i Spermosens AB

Välkommen att teckna Units i Spermosens AB Teckningstid: 9 – 23 januari 2023 Observera att vissa banker kan stänga möjligheten för teckning redan torsdagen den 19 januari 📣 Delta i en livepresentation av företaget med VD Ulrik Nilsson med möjlighet att ställa frågor i ett Teams Meeting måndag den 16:e kl 17:00, eller tisdag den…

Øresundsdagen i Investor Ugen

Copenhagen, 23 November 2020 Søren Jonas Bruun, Managing Partner i Gemstone Capital er i studiet på sammen med Michael Friis Jørgensen fra HCA Capital, Per Hansen fra Nordnet og interviewet af Mikael Bak fra Dansk Aktionærforening. Følg med fra [09:22] og hør bl.a. om hvad vi kan lære af børs-markedet i Sverige. 09.22: Nordiske fordele:…

STENOCARE has secured 15mDKK in debt financing

Copenhagen, July 13, 2019Today, STENOCARE has signed a significant contract to establish a large scale, state-of-the-art medical cannabis cultivation facility in Denmark. At the same time, STENOCARE has secured 15mDKK in debt financing which in combination with cash at hand will finance the contract. Raising the bar: For more than a year, STENOCARE has been…

MenuPay announces outcome of new public issue

Copenhagen, 16 May 2019 MenuPay AB’s (publ) (“MenuPay” or the “Company”) rights issue with preferential rights for the Company’s shareholders was subscribed to 101,6% percent. The Company’s financial position was improved by a total of 23,4mSEK of which 11,4mSEK was cash subscription. After transaction cost these proceeds will be leveraged to fuel further expansion of…